Zepbound
(Tirzepatide)
Dual-Hormone Power. Significant Results.
The First FDA-Approved GIP and GLP-1 Receptor Agonist for Weight Management
Our Zepbound (Tirzepatide) Injection is a revolutionary, once-weekly medication specifically indicated for chronic weight management. As a dual-agonist, Zepbound is the first of its kind to activate two distinct hormone receptors—GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1). This combined approach targets the brain's hunger signals while improving how your body breaks down sugar and fat, helping you achieve clinical-grade weight loss results.
Active Ingredient
Tirzepatide
Administration
A simple, once-weekly subcutaneous injection with a hidden needle design.
Dosages
Available in 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg single-dose pens.
Clinical Excellence
In clinical trials, participants on the highest dose lost an average of 48 lbs (approx. 21% of their body weight) over 72 weeks.
Dual-Action Mechanism
Targets two metabolic pathways (GIP and GLP-1) for more comprehensive appetite control.
Discreet
Ships directly to your door in climate-controlled, neutral packaging for 100% privacy.
How It Works



Create an account
Answer a few quick questions about your health. Don't worry, the information will be private and secure and will only be used by our physicians to evaluate and assess your treatment.
Receive your treatment plan
Our physicians shall confirm the recommended treatment after just a few moments, and your order will then be finalized.
Get your medication
We shall promptly ship your treatment medication to your address.
Your Privacy is Our Priority
Every Aria Health Rx order arrives in an unmarked mailing box
There are no mentions of any medication or Aria Health on the exterior
Your privacy is preserved from the moment it leaves our pharmacy to the moment it reaches your door

